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Abstract
Optimized protocols for achieving high-yield expression, purification and reconstitution of membrane proteins are required
to study their structure and function. We previously reported high-level expression in Escherichia coli of active BmrC and
BmrD proteins from Bacillus subtilis, previously named YheI and YheH. These proteins are half-transporters which belong to
the ABC (ATP-Binding Cassette) superfamily and associate in vivo to form a functional transporter able to efflux drugs. In this
report, high-yield purification and functional reconstitution were achieved for the heterodimer BmrC/BmrD. In contrast to
other detergents more efficient for solubilizing the transporter, dodecyl-ß-D-maltoside (DDM) maintained it in a drug-
sensitive and vanadate-sensitive ATPase-competent state after purification by affinity chromatography. High amounts of
pure proteins were obtained which were shown either by analytical ultracentrifugation or gel filtration to form a
monodisperse heterodimer in solution, which was notably stable for more than one month at 4uC. Functional reconstitution
using different lipid compositions induced an 8-fold increase of the ATPase activity (kcat,5s
21). We further validated that
the quality of the purified BmrC/BmrD heterodimer is suitable for structural analyses, as its reconstitution at high protein
densities led to the formation of 2-D crystals. Electron microscopy of negatively stained crystals allowed the calculation of a
projection map at 20 A ˚ resolution revealing that BmrC/BmrD might assemble into oligomers in a lipidic environment.
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Introduction
Transport in and out of a cell or between its intracellular
compartments is a vital process requiring many dedicated
membrane proteins, and one of the largest families involved in
these tasks is the ABC (ATP-binding cassette) transporters [1].
These transporters are ubiquitously distributed, from bacteria to
man, and function by coupling ATP hydrolysis to vectorial
transports, either import or export, of a wide diversity of substrates
including amino acids, ions, sugars, complex organic molecules,
peptides and even large proteins [2]. The basic architecture of an
ABC transporter is four core domains with two hydrophilic
nucleotide-binding domains (NBDs) that hydrolyze ATP to fuel
the transporter and two transmembrane domains (TMDs) that
allow the substrate to cross the membrane [3]. For importers, an
additional subunit is involved in the capture and the delivery of the
substrate to the TMDs [2]. The four core domains are either fused
into a single polypeptide (full size transporters) or borne on
separate polypeptides, from two to four. Transporters with one
NBD genetically fused to one TMD are known as half transporters
and work either as homodimers or heterodimers [4].
Some ABC members are involved in multidrug resistance
(MDR) phenotypes due to their ability to efflux many structurally
unrelated compounds [5]. Multidrug transporters represent a
major threat to public health because they are responsible for
cellular resistance to antibiotic, antifungal, antiparasitic and
anticancer drugs in bacteria, yeast, protozoan parasites and
human cancerous cells, respectively [5,6,7]. In humans, three
ABC transporters are mainly involved in MDR phenotypes,
namely the P-glycoprotein (Pgp or ABCB1), MRP1 (ABCC1) and
BCRP (ABCG2) [8,9]. Both Pgp and MRP1 are full size
transporters while BCRP is a half transporter that self-associates
to create a functional transporter [9]. Since the discovery of LmrA,
a Pgp like half transporter in Lactococcus lactis [10], many bacterial
ABC transporters have been assigned a putative MDR function
based on bioinformatic classification [11]. New MDR bacterial
ABC transporters have since been characterized at the molecular
level [12,13,14,15,16]; notably the solving of the first high-
resolution 3-D structure of a MDR ABC exporter [16,17],
suggesting that the minimal functional unit of these transporters
(or related ones such as MsbA) is a homodimer. This is consistent
with biochemical and other structural studies [17,18,19,20,21].
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ABC transporters function as heterodimers [22,23,24,25,26].
Interestingly, the presence of two different subunits allows such
transporters, e.g. LmrC/LmrD, to work in an asymmetric mode
regarding nucleotide binding and hydrolysis by their two NBDs
[27]. This essential feature is shared with many eukaryotic ABC
transporters including members of the human C family, such as
MRP1 and CFTR, or the TAP1/TAP2 heterodimer [28,29,30].
To date, however, apart from this initial report on detergent
solubilized LmrC/LmrD, there is a lack of information concerning
the functioning mechanism of bacterial MDR ABC transporters
that work as heterodimers.
We recently characterized a new heterodimeric ABC transporter
from Bacillus subtilis, YheI/YheH [31], and given its significant
homology to LmrC/LmrD of L. lactis, we hereafter call it BmrC/
BmrD. Importantly,theoverexpression of both subunits, BmrCand
BmrD, were required to detect a multidrug transport activity in
inside-out E. coli membrane vesicles. Moreover, expression of both
bmrC and bmrD genes was strongly increased upon exposition of B.
subtilis to many antibiotics, supporting a role for BmrC/BmrD as a
new multidrug transporter [31]. Here, we have set up a purification
protocol for this heterodimeric transporter allowing the recovery in
high yield of an active, stable and monodisperse heterodimeric
transporter in a detergent solubilized state. An optimized reconsti-
tution protocol into proteoliposomes allowed this transporter to
display a high ATPase activity, about 8-times higher than in
detergent solution. Moreover, 2-D crystals of this transporter were
obtained in membrane in an ADP/vanadate trapped conformation
thus confirming the quality of the preparation. Negative staining of
these 2D crystals allowed us to obtain a projection map at a
resolution of 20 A ˚. This reveals a possible supramolecular
organization of BmrC/BmrD heterodimers in a lipidic environ-
ment.
Results
Overexpression of BmrC/BmrD
Previously, we co-expressed BmrC and BmrD-His6 in E. coli
BL21(DE3)thereby obtainingmembrane vesicles highly enriched in
these two proteins, and we showed that they were both required to
detect a transport activity of several drugs [31]. Initial attempts to
purify this heterodimer transporter from these vesicles led to some
loss of the untagged subunit (i.e. BmrC) when Ni
2+ affinity
chromatography was performed in the presence of different
detergents (see Figure S1). Thus, although the two subunits interact
in the membrane, addition of a high concentration of detergent
required toefficientlysolubilizethetransporterpresumably weakens
the interaction between them (or the association with stabilizing
lipids). This led to a partial loss of the untagged subunit during the
subsequent affinity chromatographic step. To overcome this hurdle,
we decided to add an N-terminal hexahistidine tag to the BmrC
subunit and thus to work with both subunits tagged. Higher
amounts of His-tagged BmrC were obtained in the membrane
preparations leading to an excess of this subunit as compared to the
His-tagged BmrD (Fig. S1). Yet, no difference in substrate transport
between the mono-tagged and the bi-tagged constructs was
observed for membrane vesicles containing overexpressed BmrC/
BmrD (data not shown). A typical preparation starting from 1 liter
of culture medium yielded ,150 mg of total membrane proteins, of
which at least 50% corresponded to BmrC/BmrD (Fig. S1).
Solubilization screen
Membrane preparations highly enriched in BmrC/BmrD were
incubated with a sampling of commonly used non-ionic and
zwitterionic detergents. The non-ionic detergents tested were n-
dodecyl-ß-D-maltoside (DDM) and its thio-derivative n-dodecyl-ß-D-
thiomaltoside (DOTM), n-octyl-ß-D-glucoside (OG) and 6-O-(n-
heptylcarbamoyl)-methyl-a-D-glucopyranoside (HECAMEG). As
shown in Figure 1a–b, DDM performed best among the tested
non-ionic detergents, although the yield was rather low with less than
30% of the protein being solubilized. Similar extraction yields were
obtained with DOTM (not shown). In contrast, OG was unable to
solubilize BmrC/BmrD. The zwitterionic detergents tested were
lauryldimethylamine oxide (LDAO), n-dodeclyphosphocholine (FC-
12), n-Hexadecylphosphocholine (FC-16), n-dodecyl-N,N-dimethyl-
3-ammonio-1-propanesulfonate (Z3-12), and and 3-[(3-cholamido-
propyl)-dimethylammonio]-1-propane sulfonate (CHAPS). With the
exception of CHAPS, all solubilized BmrC/BmrD more efficiently
than the non-ionic detergents. The two fos-cholines had by far the
best extraction efficiencies, close to 100%. Additionally, a mixture of
0.1% DDM and 1% polyoxyethylene-8-dodecylether (C12E8)t h a t
was successfullyused to solubilize Sav1866 [17], was also tried but did
not give any improvement as compared to DDM alone (not shown).
All mild detergents (i.e. with an extraction efficiency ,40%)
solubilized BmrD slightly better than BmrC (Fig. 1b). Given the
excess of BmrC in the membrane fraction, this observation suggests
that excess subunits that are not assembled into heterodimers are
misfolded in the membrane and therefore less readily solubilized (see
also the Discussion section). In contrast, LDAO and Z3.12 appeared
to solubilize the BmrC subunit more efficiently than BmrD. This
effect was even more pronounced using the stronger detergents (i.e.
FC12 and FC16) that solubilized almost entirely both proteins. This
second category of detergents thus maintained an excess of BmrC
subunit in the solubilized fraction.
Purification of BmrC/BmrD using four selected
detergents
On the basis of their high efficiency in the solubilization screen,
FC12 and FC16 were further retained for purification of BmrC/
BmrD. In addition, despite their low extraction efficiency, LDAO
and DDM were also included in our purification trials because
they have been successfully used for purifying and characterizing
other ABC transporters [32,33], and are among the preferred
detergents for crystallization of membrane proteins [34]. Mem-
brane solubilization and Ni
2+-chelate affinity chromatography
were carried out with each of these four detergents. As expected,
protein yield correlated with extraction efficiency. Fos-cholines
allowed purifying 40–50 mg of protein per liter of culture medium,
while protein yields were about ten times lower when DDM or
LDAO were used. Analysis by sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE) reveals that, for each
detergent, the proteins were recovered with a similar degree of
purity (Fig. 1c). However, the apparent stoichiometry of the
purified BmrC and BmrD subunits seems to be dependent on the
detergent used. Although the intensity of the Coomassie-stained
bands is an approximation of the actual amount of protein, an
apparent excess of BmrC was observed in the fos-choline purified
samples (cf. Fig. 1c). Thus, DDM was the only detergent that
allowed the purification of both subunits in an apparent equimolar
complex.
To further characterize the purified complex, it was loaded onto
a Superdex 200 10/300 GL column, previously equilibrated with
0.05% (w/v) DDM in the mobile phase. This condition was
reported not to rescue aggregation of a protein initially solubilized
by a different detergent [35]. As shown in Figure 1d, purification of
the complex in FC12 or LDAO yields a polydisperse and
substantially aggregated protein. In contrast, BmrC/BmrD
purified in FC16 or DDM is not aggregated, with only DDM
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peak that elutes at ,10.5 ml. In agreement with these observa-
tions, measurements of the ATPase activity of the complex
purified in different detergents showed that only DDM-purified
BmrC/BmrD was able to hydrolyse ATP to a significant level.
The three other detergents led to an ATPase activity of at most
12% of that obtained with the DDM preparation (Fig. S2). In
addition, when BmrC/BmrD purified in the presence of FC16 or
LDAO was used to grow 2-D crystals (see below), only protein
aggregates were observed by electron microscopy in the
preparation.
Thus, based on the apparent homogeneity and high ATPase
activity, DDM was chosen as the detergent for BmrC/BmrD
purification. Further optimization of the purification protocol
consisted in shortening the induction time for protein production
from 16 to 6 hours. This led to an increase of solubilization
efficiency up to 50% (not shown) and thus higher protein yields.
Presumably, the 16 hours induction time resulted in a higher
amount of misfolded transporter in the membrane. This misfolded
protein was refractory to DDM solubilization. Using a 6 h.
induction time, a typical preparation from 1 liter of culture
medium yielded ,12 mg of purified BmrC/BmrD in detergent
solution, with an ATPase activity of 231617 nmol?min
21?mg
21
(0.5660.04 s
21; n=5 measurements with two different purifica-
tion batches).
The ATPase activity of the individual BmrC and BmrD
subunits were also analyzed separately after purification in DDM.
However, although membrane expression levels of the separate
BmrC and BmrD proteins were similar to that obtained when they
were jointly overexpressed [31], the solubilization step was found
to be quite inefficient for the isolated subunits and affinity
chromatography separations resulted in highly contaminated
proteins, especially for the BmrD preparation (Fig. S3a). This
result suggests that, in the absence of its twin subunit, a single
subunit is unable to associate into a stable homodimer and likely
folds improperly in the membrane. Compared with BmrC/BmrD
purified in the same manner, a much lower level of ATPase
activity was obtained for fractions containing BmrC or BmrD
alone (,80 and ,60 nmol?min
21?mg
21, respectively; Fig. S3b)
that were not sensitive to vanadate inhibition. As a control, a
double mutant where the invariant Lys residue in the Walker-A
motif of each subunit was mutated to an Ala residue (BmrC
Figure 1. Purification of BmrC/BmrD using different detergents. (a) BmrC/BmrD solubilization by non-ionic and zwitterionic detergents was
performed at 2 mg/ml protein and 10 mg/ml detergent and assessed by Coomassie Blue stained SDS-PAGE of the soluble (S) and insoluble (P)
material obtained from 15 mg of total protein sample (T). Note that the strong densities observed in some of the pellet bands probably arise from
difficulties encountered while resuspending the pellet that led to inhomogeneous samples. Black arrowhead, BmrD; grey arrowhead, BmrC. (b) The
intensities of the bands corresponding to the S and T samples were quantitated using Image Gauge software (Fuji Film Science Lab) and the
solubilization yields were calculated as the ratio of each protein in the supernatant (S) relative to its amount in the membrane fraction (T). (c, d)
Protein purified by nickel affinity chromatography in the presence of the indicated detergents was analyzed by (c) Coomassie Blue stained SDS-PAGE
(5 mg per lane, except for DDM : 4 mg) and (d) size-exclusion chromatography performed on a Superdex 200 10/300 GL column using 0.05% (w/v)
DDM in the elution buffer. Elution volumes of proteins used for column calibration are indicated above: ferritin (F, 440 kDa), aldolase (AD, 158 kDa),
albumin (AB, 67 kDa), Vo: void volume. The intensities of the BmrC and BmrD bands in the polyacrylamide gel in c were quantitated and the ratio
BmrC:BmrD (ratio C:D) was indicated under each lane. Black arrowhead, BmrD; grey arrowhead, BmrC.
doi:10.1371/journal.pone.0019677.g001
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insensitive to vanadate inhibition (Fig. S3b). Presumably, the
vanadate-insensitive ATPase activity in these different fractions is
due to some contaminants bearing an ATPase activity.
Characterization of DDM-purified BmrC/BmrD
Analysis by size-exclusion chromatography (SEC) of the whole
complex purified after a 6 hours induction shows an elution profile
with a more symmetrical peak (cf. Fig. 2a). This sharper, Gaussian-
like peak, reveals that the reduction of the induction time not only
increased the purification yield, but also improved the homogeneity
of the purified proteins [36]. Silver staining of the material eluted in
this peak shows that the BmrC/BmrD complex was relatively pure
as low molecular weight contaminants were removed and only a
very faint contaminant remained with an apparent molecular mass
of ,100 kDa. Comparison of the elution volume of the major peak
with that of protein standards of known size allows an estimation of
the molecular mass of the BmrC/BmrD detergent complex of
,310 kDa (more precisely the Stokes’ radius RS is ,6.1 nm). This
mass is about twice the protein part of a BmrC/BmrD/detergent
complex, given that the theoretical molecular masses of 66His-
tagged BmrC and BmrD proteins are 67 and 77 kDa, respectively.
A comparable molecular mass (300630 kDa) was obtained by this
approach for the homodimeric BmrA transporter (66.2 kDa for the
monomer), which was indeed shown to be a homodimer in a DDM
solution using analytical ultracentrifugation [21].
To precisely assess the oligomeric state of BmrC/BmrD in
DDM solution, analytical ultracentrifugation experiments were
also performed. Data from a typical sedimentation velocity
experiment are shown in Figure 2b–d. The experimental points
were fitted in terms of distribution of non-interacting particles and
the goodness of the fit was checked by the low values of the
residuals and their random distribution. The majority of the
protein sediments at s20,w=8.6 S (sexp=5.8 S), a value close to that
measured for the dimeric BmrA (s20,w=8.960.3 S [21]).
Measurements with interference optics (not shown) led to an
estimate of the amount of bound detergent plus lipids of 0.5 g/g
(compared to 1.5 g/g estimated for BmrA). Such a complex of
BmrC/BmrD/DDM (neglecting the possible lipids associated), if
slightly elongated or globular (frictional ratio of 1.5-1.25,
corresponding to a hydrodynamic radius RH of 6.1-5.0 nm) would
sediment at s20,w values of 7.2–8.7 S. On the other hand, each of
the isolated subunits would have s20,w values of 4.6–5.5S, and a
dimer of heterodimers would have s20,w values of 11–14 S. From
these calculations, and the comparison with BmrA, it is clear that
the main species in DDM solution is the BmrC/BmrD
heterodimer. Some larger species were also detected at higher
s20,w values (see Fig. 2d) consistent with the tendency of the
heterodimer to oligomerize (see below).
Having shown that BmrC/BmrD were essentially monodisperse
in DDM and that they behaved as a heterodimer, we next studied
the stability of this complex during a long-term storage at 4uC. This
parameter has been empirically defined as one of the key factors for
successful crystallization of membrane proteins [36]. Sedimentation
velocity experiments weretherefore performed directly after the size
exclusion chromatography. They show a high level of homogeneity
of purified BmrC/BmrD, which was essentially maintained after
storing the protein 41 days at 4uC. More than 70% of the protein
was recovered (Figure 3a), with the remaining being possibly stuck
ontheglassware.Theeffectofstorage at4uC ontheATPaseactivity
of BmrC/BmrD was also monitored in a separate experiment. As
shown in Figure 3b, ,80% of the initial ATPase activity was
conserved after 39 days of storage.
ATPase activity of BmrC/BmrD in DDM is sensitive to
vanadate and stimulated by Hoechst
We have previously shown that in E. coli membranes, the
ATPase activity of BmrC/BmrD was sensitive to vanadate
inhibition [31], and consistent with our previous result, 8162%
of the ATPase activity of DDM solubilized BmrC/BmrD was
inhibited by 0.5 mM vanadate. As Hoechst 33342 was previously
found to be a substrate efficiently transported by BmrC/BmrD
[31], its effect on the ATPase activity on purified BmrC/BmrD
was studied. Addition of increasing concentrations of Hoechst
stimulated ATP hydrolysis by BmrC/BmrD about two-fold when
the Hoechst concentration reached ,10 mM (cf. Fig. 4b, light gray
trace). These results reveal that not only the ATP-binding sites of
BmrC/BmrD were kept intact throughout the purification
protocol, but also that the drug-binding site as well as the
conformational coupling between both sub-domains are functional
in the DDM purified transporter. Other substrates shown
previously to be transported by BmrC/BmrD, namely mitoxan-
trone, doxorubicin and BCECF [31], or capable to inhibit the
Hoechst transport such as vinblastine were also tested but they
resulted in a modest stimulation of about 20% of the ATPase
activity of BmrC/BmrD (not shown).
Reconstitution of BmrC/BmrD into proteoliposomes
BmrC/BmrD was reconstituted into proteoliposomes after
detergent removal by hydrophobic adsorption onto polystyrene
beads (Biobeads) starting from a mixture of lipid/protein/DDM.
This procedure has invariably led to the reconstitution of different
membrane proteins in unilamellar proteoliposomes, homogeneous
in size, with a low ionic permeability and total protein
incorporation (reviewed in [32,37,38]). Different lipid mixtures
were tested including egg-phosphatidylcholine (PC)/egg-phospha-
tidic acid (PA), PC/PA/cholesterol (Chol), E. coli Lipids,
dioleoylphosphatidylcholine (DOPC)/dioleoylphosphatidylgly-
cerol (DOPG) and DOCP/cardiolipin (CL), and ATPase activities
of the resulting proteoliposomes were measured. In all cases,
ATPase activity drastically increased, up to 8-fold compared to the
protein in detergent. The highest ATPase activity, ,2 mmol/min/
mg protein, was attained when reconstitution was performed with
PC and PA (9:1 molar ratio; Fig. 5a). Although chemically similar,
the mixture DOPC/DOPG resulted in much lower ATPase
activity. When reconstitution was performed with E. coli lipids
(total polar extract), the ATPase activity of BmrC/BmrD was
,30% lower (n=5). Finally, addition of cardiolipin to the
reconstitution mixture was detrimental to BmrC/BmrD ATPase
activity. Proteoliposomes were then analyzed by cryo-electron
microscopy. As expected, they showed a homogeneous population
of unilamellar vesicles of 100–150 nm diameter. Importantly, the
lipid bilayers were continuous. No deformed or open vesicles were
found that would be associated with an increased passive
permeability (Fig. 5b). The incorporation and protein repartition
among the population of vesicles were evaluated by two additional
experiments. First, BmrC/BmrD were reconstituted at different
lipid/protein ratio and specific ATPase activities were measured.
At low protein densities (lipid/protein molar ratio of 40 and 100),
the ATPase activities observed were similar (Fig. 5c). Next,
proteoliposomes were submitted to discontinuous flotation gradi-
ents, as previously described [37], with successive layers containing
30, 20, 10, 5 and 2.5% sucrose. The fractions were collected and
analyzed for protein contents by immunoblot using anti-His
HisProbe-HRP revealing that most of the BmrC/BmrD were
found at 2.5%–5% interface. This corresponded to the expected
densities for proteoliposomes (Fig. 5d). Moreover, a very faint
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PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e19677Figure 2. DDM-purified BmrC/BmrD is monodisperse. (a) Size-exclusion chromatography of DDM-purified protein (,0.3 mg) was performed
as indicated in fig. 1d. Inset: Silver-stained SDS-PAGE of protein eluted at 10 ml. Black arrowhead, BmrD; grey arrowhead, BmrC. Vo: void volume. (b–d)
Samples of nickel-affinity purified BmrC/BmrD (0.85 mg/ml) kept frozen at 280uC after flash freezing in liquid N2, were thawed and analyzed by
sedimentation velocity measurements at 20uC and 42000 revolutions per minutes. (b) Superposition of selected sedimentation profiles obtained at
278 nm and the corresponding fitted curves using continuous size distribution analysis. (c) Superposition of the residuals. (d) c(s) curves for the stock
protein (continuous line) and the protein diluted 4 times in dialysis buffer (dashed line).
doi:10.1371/journal.pone.0019677.g002
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amount of proteins aggregates during reconstitution.
We also characterized the morphology and ATPase activity of
proteoliposomes obtained after detergent removal from a PC/PA
mixture solubilized in different detergents. Indeed, lipid/detergent
intermediates formed during detergent removal are specific for the
detergent, so that the morphology of the resulting liposomes
depends on the detergent used (for review see [38]). The highest
ATPase activity (,2 mmol?min
21?mg
21) was measured when
proteoliposomes were prepared with DM (Fig. S4). No significant
differences were obtained between DM and DDM mediated
reconstitutions, the ATPase activities of the resulting proteolipo-
somes were 1.960.4 (n=5) and 1.760.6 mmol?min
21?mg
21
(n=10), respectively. In contrast to previous reports on other
ABC transporters [32], reconstitution using Triton X-100 was less
favorable for BmrC/BmrD ATPase activity than the maltoside-
derivatives (Fig. S4). Finally, reconstitution with OTG gave
essentially multilamellar proteoliposomes resulting in a low
ATPase activity (Fig. S4).
Direct incorporations into preformed liposomes destabilized
with a sub-solubilizing concentration of DDM were also
performed. This reconstitution method has been shown to ensure
a unique orientation of proteins into liposomes with large
extramembranous domains of membrane proteins facing the
extracellular medium [37,38]. Here, this led to a ,20% increased
of the ATPase activity as compared to incorporation from a fully
solubilized mixture of lipid/proteins/detergent. Thus we can
estimate that most of the proteins (.80%) was incorporated in the
right orientation (i.e. inside-out topology) competent for ATP
hydrolysis when reconstituted from a fully solubilized mixture of
lipid/proteins/detergent.
Because the reconstitution protocol using fully solubilized lipids
yielded a high and consistent ATPase activity, we chose this
technique to determine the kinetic constants for ATP hydrolysis by
BmrC/BmrD incorporated into proteoliposomes prepared from
PC/PA solubilized by DDM (Fig. 4a). Data obtained using
increasing ATP concentrations were fitted to the Michaelis-
Menten equation with a calculated Vmax of 1.9360.08 mmol?
min
21?mg
21 (kcat,4.7 s
21) and a Km value of 1.060.1 mM for
ATP. Like the DDM-solubilized transporter, the ATPase activity
of the reconstituted BmrC/BmrD was stimulated upon Hoechst
addition, irrespective of the lipids used during the reconstitution
(Fig. 4b). Our data show that the ATPase activity of BmrC/BmrD
can be increased 8 times upon reconstitution into proteoliposomes.
2-D crystallization of BmrC/BmrD
2-D crystals were obtained after addition of lipids at low lipid/
protein ratio 0.5–1 (w/w) followed by slow detergent removal
using Bio-Beads. Vesicles homogeneous in size, 100–300 nm
diameter, and containing densely packed proteins were obtained
with several lipid mixtures including e.g. dimyristoylphosphatidyl-
choline, DOPC, PC/PA (9/1, w/w), and PC/PA/cholesterol or
PC/PA/cardiolipin (7/2/1, w/w/w). In the absence of ATP/
MgCl2, 2D crystals were never obtained although proteins were
present at high densities in the membrane, as seen by negative
staining. Strikingly in all cases, irrespective of the lipids used,
membranes of proteoliposomes were not flat as usually observed in
2D crystallization trials but showed several deformations or ripples
(Fig. 6a). It is worth mentioning that similar deformations have
been observed after reconstitutions of MsbA in the absence of
ATP/MgCl2 (D. L., unpublished data). However, when reconsti-
tutions were performed in the presence of ATP/MgCl2/vanadate,
deformation of the membrane was not observed and several
vesicles contained proteins packed in 2-D arrays. The size of the
crystalline patches increased with the duration of reconstitution
and the largest 2D crystals were obtained after 3 days of
reconstitution. The best conditions were found after reconstitution
in the presence of PC/PA or PC/PA/cholesterol lipid mixtures,
leading to large tubular shaped 2-D crystals up to 261 mm in size
(Fig. 6b, 6c). Within these vesicles, regular crystalline patches of
approximately 3006300 nm were found and they were further
analyzed using 2D crystal software (see Materials and Methods).
The calculated power spectrum of negatively stained 2-D crystal
images showed clear diffraction spots up to 21 A ˚ resolution before
image unbending (Fig. 6d). Comparison of phase residuals with the
ALLSPACE program revealed p121-b symmetry and a symme-
trized projection map was calculated at 20 A ˚ resolution (Fig. 6f,
see also Table S1 and Table S2). The unit cell parameters were
a=122 A ˚, b=236 A ˚ and gamma=90u with one unit cell
containing two different entities of ,110 A ˚6110 A ˚ related by a
screw axis along the b axis (e.g. one entity is outlined by a light
grey square in Fig. 6e). The surface of each entity is significantly
larger than the surface of the homodimeric bacterial half
transporters MsbA or Sav1886 in post hydrolytic conformation
of 75 A ˚650 A ˚ at the level of the NBDs. Moreover, this is close to
the dimensions of 11611 nm reported for the dimer of the yeast
full transporter Pdr5, i.e. made of 4 NBDs [39]. Thus we propose
that each entity of 110 A ˚6110 A ˚ is made of at least a dimer of
BmrC/D heterodimers.
Figure 3. Stability of DDM-purified BmrC/BmrD. (a) After nickel-affinity and size-exclusion chromatography in the presence of DDM, purified
BmrC/BmrD protein at 0.11 mg/ml was immediately subjected (day 0) to sedimentation velocity measurements or incubated at 4uC for 12 or 41 days
before performing analytical ultracentrifugation experiments at 42000 rpm and 20uC. The superposition of the c(s) curves from data obtained at
278 nm at different times is shown. (b) ATPase activity of nickel-affinity purified BmrC/BmrD was determined in 0.05% (w/v) DDM after incubation at
4uC for the indicated times. The values are expressed as the mean 6 SD for three measurements, relative to the ATPase activity obtained without
prior incubation at 4uC (244610 nmol?min
21?mg
21).
doi:10.1371/journal.pone.0019677.g003
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In this study, we devise an efficient protocol to purify in high
yield, and in a stable and monodisperse state, a new heterodimeric
multidrug ABC transporter called BmrC/BmrD. This is a
prerequisite step for biochemical and structural characterization
especially for crystallization attempts [36]. For heterodimers or
transporters with several subunits, if only one subunit is tagged the
purification protocol must maintain the tight interactions between
all components of the complex throughout the procedure, notably
during the solubilization step where high concentrations of
detergent are usually required [40,41]. Clearly, the interaction
Figure 4. Reconstitution of BmrC/BmrD into proteoliposomes. BmrC/BmrD were reconstituted at lipid to protein ratio of 40 (w/w) by
detergent removal from different solubilized mixtures of DDM/lipid/protein. (a) ATPase activity of proteoliposomes was assessed at 4 mM ATP. E. coli:
total extract of E. coli phospholipids; PC: egg-phosphatidylcholine; PA: egg-phosphatidic acid; chol: cholesterol; DOPC: dioleoylphosphatidylcholine;
DOPG: dioleoylphosphatidylglycerol; CL: cardiolipin. Lipid composition was as follows (w/w): PC/PA 9:1; PC/PA/chol 7:1:2; DOPC/DOPG 9:1; PC/CL 8:2.
(b) Cryo-electron microscopy of reconstituted proteoliposomes with EPC/EPA. All proteoliposomes were unilamellar and showed a continuous lipid
bilayer. Scale bar: 50 nm. (c) ATPase activity measured after reconstitution of BmrC/BmrD with EPC/EPA or E. coli lipids at lipid to protein ratio of 40
(w/w) and 100 (w/w). (d) Protein incorporation in proteoliposomes after fractionation in a sucrose gradient. The amount of BmrC/BmrD in every
fraction was measured by quantitation of the protein bands revealed by immunoblot (the intensity of both bands were added) and normalization to
the total amount of BmrC/BmrD loaded onto the sucrose gradient (cf. Materials and Methods). Most proteins were reconstituted in proteoliposomes
running at 2.5%–5% sucrose without significant aggregates at 30% sucrose.
doi:10.1371/journal.pone.0019677.g004
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efficiently co-purify BmrC with a hexahistidine-tagged BmrD in a
1/1 complex; the introduction of a second tag was therefore
required to overcome this hurdle. Such a problem was apparently
not encountered for one of the best-characterized heterodimeric
half-size exporters, TAP1/TAP2, which could be purified as a
stable complex when only one subunit was tagged [42,43]. The
BmrC and BmrD subunits each have 6 predicted transmembrane
helices (Figure S5) whereas TAP1 and TAP2 have 10 and 9
predicted transmembrane helices, respectively. Possibly, the
supernumerary helices in TAP1/TAP2 might confer additional
stability to the transporter after detergent solubilization [4,44,45].
Affinity-purification of other ABC heterodimers, such as LmrC/
LmrD [24], AbcA/AbcB [25] and native ABCG5/ABCG8 [46],
has been reported upon tagging of a single subunit or using an
antibody against only one subunit. However, the homogeneity of
these preparations was not assessed, e.g. by gel filtration or
analytical ultracentrifugation. Importantly, Xie and colleagues
reported that ABCG5/ABCG8 heterodimers were disrupted on
ion exchange or hydroxyapatite columns [46]. Similar to the
strategy used here, purification of recombinant ABCG5/ABCG8
heterodimers was performed after tagging each subunit [47].
While the expression levels of BmrC and BmrD in the E. coli
membrane were very high for the longest induction time used
here, the extraction efficiency was found to be surprisingly low for
many ‘mild’ detergents commonly used in membrane protein
purification. Such a huge overexpression of BmrC/BmrD
appeared actually detrimental to the solubilization step, because
a shortening of the induction time led to much higher
solubilization yields, up to 50%. Thus, the poor solubilization
yield obtained (e.g. with DDM) when the highest overexpression
was reached might actually reflect the selective extraction of the
Figure 5. Reconstituted BmrC/BmrD displays a high and substrate-stimulated ATPase activity. (a) BmrC/BmrD was reconstituted into
proteoliposomes using a mixture of PC/PA (9:1, molar ratio), and the effect of ATP/Mg
2+ concentration on the initial ATPase velocities was
determined. The solid line represents the best fit of the data to Michaelis-Menten equation (using the GraFit 5 software from Erithacus), allowing the
determination of Vmax=1.9360.08 mmol?min
21?mg
21 (kcat,4.7 sec
21) and Km=1.060.1 mM. Inset shows the Lineweaver-Burk Plot of the data. (b)
The ATPase activity of BmrC/BmrD reconstituted in proteoliposomes, prepared either with PC/PA (black) or E. coli lipids (dark gray), was studied in the
presence of increasing concentrations of Hoechst 33342. For comparison, the ATPase activity of BmrC/BmrD in 0.05% (w/v) DDM is shown (light gray).
The values are expressed as the mean 6 SD for three measurements, relative to the ATPase activity obtained without addition of Hoechst 33342.
doi:10.1371/journal.pone.0019677.g005
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conformation. This is in line with the poor solubilization efficacy
observed for each subunit alone (Fig. S3) suggesting that in the
membrane fraction and in the absence of their twin subunit, BmrC
or BmrD are not properly folded and so refractory to solubilization
by mild detergent. In contrast, the fos-cholines solubilize almost all
protein in the membrane and destabilize the BmrC/BmrD
heterodimers to a higher extent than DDM, as suggested by the
important loss of untagged subunits during affinity chromatogra-
phy (Fig. S1). This explains the variability in apparent BmrC/
BmrD stoichiometry and specific ATPase-activity upon purifica-
tion in presence of different detergents.
DDM-purified BmrC/BmrD heterodimers seem homogeneous
when analyzed by gel filtration or analytical ultracentrifugation.
Importantly, almost no monomeric species were detected in the
analytical ultracentrifugation experiments, indicating that the
destabilization of the BmrC/BmrD heterodimer during the initial
solubilization step is reversible when the detergent concentration is
lowered. Although we cannot rule out that some homodimers were
present in our preparation, this appears rather unlikely given that
(i) the propensity of our samples to readily crystallize in two
dimensions and (ii) the poor yield of single subunit purification
suggesting an instability of homodimers. In addition, under similar
solubilization conditions (i.e. 1% DDM) the homodimeric
multidrug bacterial ABC transporter BmrA was in equilibrium
between monomers and dimers [18], and thus behaved as the
BmrC/BmrD heterodimer. However, once the DDM concentra-
tion was lowered from 1% to 0.05% on the subsequent affinity
column, BmrA reformed stable homodimers [13,21].
The purified BmrC/BmrD heterodimer has a significant
ATPase activity in detergent (,200 nmol?min
21?mg
21), sensitive
to vanadate inhibition and drug activation, which can be highly
increased upon reconstitution into proteoliposomes. A remarkable
feature of BmrC/BmrD ATPase activity, which highlights the
purification quality, is its long-term stability in detergent. This
contrasts for instance with Pgp or MRP3 which were shown to
require the addition of lipids to be stable under similar conditions
[48,49]. Variable effects on the ATPase activity of different ABC
exporters have been reported following reconstitution into
proteoliposomes, with a marked stimulation for BmrA [13], a
modest stimulation for Pgp, MRP3 or TAP1/TAP2 [50,51,52] or
a three fold decrease for MsbA [53]. It is noteworthy that none of
the reconstitution reports cited above verified the lamellarity of the
obtained liposomes as done here using cryoelectron microscopy.
The presence of multilamellar liposomes in the proteoliposome
preparation can substantially diminish the ATPase activity, as
observed here for OTG-mediated reconstitutions (Fig. S4), and
could partially explain the large variability of reconstitution
previously reported for different ABC transporters. Furthermore,
the high ATPase activity measured here for BmrC/BmrD is
specific because mutation of the invariant lysine residue to an
alanine in the Walker-A motifs of both BmrC and BmrD led to an
affinity-purified mutant transporter with a low residual ATPase
activity in detergent (cf. Fig. S2b). This activity became virtually
undetectable after gel filtration and upon reconstitution into
proteoliposomes (not shown).
Either in a detergent solubilized state or reconstituted in
proteoliposomes, BmrC/BmrD ATPase activity is stimulated by its
Hoechst 33342 substrate. This observation suggests that the global
conformation of this heterodimer and its coupling mechanism is
conserved in the DDM-solubilized state. Yet, maximal stimulation
of the reconstituted transporter was achieved at lower drug
Figure 6. 2-D crystallization of BmrC/BmrD. BmrC/BmrD was reconstituted with PC/PA/cholesterol lipid mixture at 0.6 (w/w) as described in the
Materials and Methods section in the absence (a) or in the presence (b, c) of ATP/MgCl2/vanadate. (b, c) Electron micrographs of negatively stained 2-
D crystals. (d) Representation of amplitudes of Fourier components calculated for one image of a negatively stained crystal. Numbers and box sizes
correspond to the spot IQ value, with spots of the highest signal-to-noise ratio having an IQ of 1 and the lowest of 5 [84]. The three black circles are at
radii corresponding to 1/35, 1/24, 1/18 A ˚21.( e, f ) Projection maps of BmrC/BmrD at 21 A ˚ resolution calculated from merged amplitudes and phases
from five independent crystals with p1 symmetry and p121-b symmetry, respectively. Solid lines indicate density above the mean. Negative contours
are indicated by dotted lines. The lattice parameters are a=122 A ˚, b=236 A ˚ and gamma=90u. The unit cell, dark box, contains two supramolecular
entities (one being outlined by a dotted, light gray box in e), related by a screw axis along b (dotted arrow in f ). Scale bars are equal to 100 nm (a and
c), 1 mm( b).
doi:10.1371/journal.pone.0019677.g006
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coupling mechanism between transmembrane and nucleotide-
binding domains were favored upon reconstitution. While we
previously showed by using inside out vesicles that the multidrug
BmrC/BmrD transporter catalyzed the transport of several drugs
[31], not every substrate was found here to stimulate the ATPase
activity of the transporter. This observation is in agreement with
previous reports on other ABC transporters, e.g. MsbA [53], Cdr1
[54] or ABCC3 [49]. Different drugs can interact differently with
the same ABC transporter, both structurally (having different
binding sites [55]) and thermodynamically (causing different
interactions with the rate-limiting transition state [56]). Thus
different effects ranging from stimulating to inhibitory can be
elicited by different substrates on the ATPase activity of their
cognate transporter.
Despite the apparent efficiency of the reconstitution protocol
used in this work and the conservation of the coupling mechanism
in the purified BmrC/BmrD transporter, we have been unable to
detect a reliable drug transport activity in our proteoliposome
preparations. Although there is currently no satisfactory explana-
tion for this, it is noteworthy that a successful reconstitution
protocol to monitor peptide transport using highly purified TAP1/
TAP2 took several years to be achieved, and this exemplifies the
intrinsic difficulty when one works with membrane proteins
[42,51,57]. Possibly, an additional component present in the E. coli
membrane vesicles but missing in our reconstitution protocol
might be required. Very recently, HorA was shown to lose its
transport activity when PE was replaced with PC in the lipid
mixture used for reconstitution [58] and purified LmrC/LmrD
was shown to contain one or two molecules of cardiolipin
associated with it [59]. Addition of cardiolipin and varying the
ratio and nature of commonly used lipids did not allow us to
monitor some transport with reconstituted BmrC/BmrD, and
whether some specific or unusual lipids are necessary for the drug
transport activity of BmrC/BmrD will need further investigation.
The quaternary structure of BmrC/BmrD is a heterodimer in
detergent solution, but can be assembled into a higher oligomeric
form in a lipid membrane environment. The quaternary structure
of ABC transporters is a highly debated question, since higher
oligomeric states than the minimal functional unit (i.e. two TMDs
plus two NBDs) have been reported for various ABC transporters,
including CFTR [60,61,62,63], BCRP [64,65,66,67] or ABCA1
[68] (for a recent review see [69]). For example, MRP1 contains
two asymmetrical NBDs, one of which with non canonical residues
like those in BmrC [31], and was reported to be monomeric in
detergent solution and dimeric after reconstitution into a lipid
membrane [70]. Interestingly, the oligomeric state has been
proposed to regulate the function of some ABC transporters, e.g.
ABCA1 [68] or BCRP [66,71]. Phosphorylation of the latter by
the Pim-1L protein kinase promotes its multimerization and
modulates the BCRP-mediated drug resistance phenotype in
prostate cancer cells [66]. However, X-ray structures available for
ABC exporters (full-length murine P-glycoprotein and half-size
homodimeric ABC transporters, MsbA or Sav1886), have been
solved in a detergent solution. In this context, 2D crystallization
can provide information, although at lower resolution, on protein
assembly in a lipidic environment and on conformational changes
triggered by the binding of effectors. For instance, the shape of
membranes and 2D crystals of BmrA were modified upon ATP
binding [72]. For membrane bound MsbA, helical arrays of the
transporter were obtained and their analysis by Ward and
colleagues showed that MsbA remains in an outward facing
conformation when trapped in three different transition states
using different combinations of nucleotides and inhibitors [73].
For human P-glycoprotein, a central cavity was observed in the
nucleotide free state, as opposed to vanadate trapped states, and
intermediate conformations were also detected in the presence of
ADP alone [74]. Here, crystals of BmrC/BmrD were obtained
only in an ADP/Vi trapped conformation, and the projection map
calculated at 20 A ˚ resolution showed two entities of
,110 A ˚6110 A ˚ that could accommodate four NBDs. This
highlights the possibility that BmrC/BmrD associates into dimers
of heterodimers in the membrane. Further experiments are
currently in progress to improve the quality of the 2D crystals
and to obtain a more detailed description of protein/protein
interactions in the membrane. Yet, given the paucity of structural
data for asymmetric transporters in this conformation and in a
lipid membrane, this work represents an important contribution to
the structural understanding of ABC transporters in general.
Materials and Methods
Protein overexpression
yheI (bmrC) and yheH (bmrD) genes were amplified from Bacillus
subtilis 168 genome and cloned into a modified pET21b(+) vector
for introducing one His6-tag at the N-terminus of BmrC and
another one at the C-terminus of BmrD. Protein overexpression in
Escherichia coli BL21(DE3) and isolation of the membrane fraction
enriched with BmrC and BmrD proteins were performed as
described [31], except that the induction time was reduced to
6 hours.
Detergent screen and protein purification
The resulting membrane fraction was solubilized at a
detergent/protein ratio of 5–10 (w/w) in buffer A (50 mM Tris-
HCl pH 8, 100 mM NaCl, 15% (v/v) glycerol, 5 mM ß-
mercaptoethanol, 10 mM imidazole) with the following deter-
gents: DDM, DOTM, OG, HECAMEG, LDAO, FC-12, FC-16,
Z3-12 and CHAPS. After incubation for 2–3 hours at 4uC, soluble
and insoluble fractions were separated by centrifugation at
180 000 g for 60 min and analyzed by SDS-PAGE. The soluble
fraction was then incubated with 1/10 (v/v) of Ni
2+-IDA resin
(Prochem) for 1 h. The resin was washed with 25 column volumes of
buffer A9 (buffer A supplemented with 20 mM imidazole and
0.005% (w/v) FC-16, 0.05% (w/v) DDM, 0.05% (w/v) LDAO or
0.1% (w/v) FC-12). Elution was done in the same buffer but in the
presence of 250 mM imidazole. Purified proteins were dialysed
against 50 mM Tris-HCl pH 8, 50 mM NaCl, 10% (v/v) glycerol,
5 mM ß-mercaptoethanol, in the presence of the same detergent
and at the same concentration as the elution buffer. All steps were
carried out at 4uC or on ice. Purified proteins were frozen in liquid
N2 and stored at 280uC. Protein concentration was determined
using the Bradford assay (Coomassie Plus, Pierce). Size-exclusion
chromatography (SEC) of 0.1–1 mg affinity-purified proteins was
performed on a Superdex 200 column (10/300 GL, GE Healthcare),
using buffer B (50 mM Tris-HCl pH 8, 150 mM NaCl, 10% (v/v)
glycerol, 5 mM ß-mercaptoethanol, 0.05% (w/v) DDM) as the
running buffer.
Analytical ultracentrifugation
Samples from the affinity chromatography were used either
directly or submitted to an additional SEC step. Major peak
fractions from SEC experiments were pooled and the BmrC/
BmrD proteins were kept at 4uC for the indicated times before
sedimentation-velocity experiments were run. Analytical ultracen-
trifugation experiments were performed on a XLI Beckman
ultracentrifuge, at 20uC and 42000 rpm and analyzed as described
previously [75,76]. The reference solvent used was without
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molar mass and partial specific volume of 144.97 kDa and
0.745 ml/g were calculated and a refractive index increment of
0.187 g/ml was used. For DDM a partial specific volume of
0.82 ml/g and a refractive index increment of 0.143 g/ml were
used [77]. A solvent density of 1.026 g/ml and a viscosity of 1.33
cP were measured at 20uC. The c(s) analysis [78] and conversion of
the experimental values of the sedimentation coefficients, sexp,t o
corrected values, s20w, were done using a partial specific volume
for the protein-DDM complex of 0.78 ml/g.
Reconstitution of BmrC/BmrD
Proteoliposomes were prepared from a ternary protein/lipid/
detergent mixture by adsorption of detergent onto polystyrene
beads (Bio-Beads SM-2, Biorad) according to [79]. Different lipids
as indicated (from Avanti Polar Lipids), stored in chloroform, were
mixed and evaporated under N2 gas. After complete evaporation
of chloroform under vacuum, the lipidic film was solubilized for
16 h at a detergent/lipid ratio of 2–3 (w/w) and a lipid
concentration of 4 mg/ml, in 50 mM Tris-HCl pH 8, 150 mM
KCl, 25 mM NaCl, 4% (v/v) glycerol, 1 mM ß-mercaptoethanol.
The BmrC/BmrD proteins were incubated for 15 min with the
lipid/detergent mixture at a lipid/protein ratio of 40 (w/w), and 3
successive additions of Bio-Beads (first followed by a 2-h
incubation, then twice by a 1-h incubation) were performed at a
Bio-Beads/detergent ratio of 20 (w/w). For direct incorporation,
preformed liposomes of 4 mg/ml PC/PA (9/1 w/w) were treated
with 2.4 mg/ml DDM leading to the saturation of membrane with
DDM [80]. Protein was added at a lipid to protein ratio of 40 (w/
w). The detergent was removed using Bio-Beads as described
above. All steps were carried out at room temperature.
Proteoliposomes were kept at 4uC and activity measurements
were measured within 48 h.
The incorporation of BmrC/BmrD in liposomes was measured
after reconstitution at a lipid/protein of 40 (w/w) from fully
solubilized PC/PA lipids. Proteoliposomes were submitted to
discontinuous flotation gradients as previously described with
successive layers containing 500 ml of 30, 20, 10, 5 and 2.5%
sucrose concentration (w/w) using a TLA 100 centrifuge tube
(11654 mm) [37]. After 16-hour centrifugation at 4uC and
25000 rpm in a TLA 100 rotor (241156g), the fractions were
collected and 10 ml of each fraction was analyzed for protein
contents by immunoblot using HisProbe-HRP (Thermo Scien-
tific). The intensities of the bands corresponding to BmrC/BmrD
were quantitated using Image Gauge software (Fuji Film Science
Lab) and normalized to the total amount of BmrC/BmrD in the
gradient.
ATPase activity
The ATPase activity of BmrC/BmrD was measured using an
enzymatic assay that allows ATP regeneration to be coupled to
NADH oxidation, which is recorded at 340 nm. ATPase activity
of BmrC/BmrD in detergent (10 mg) was measured at 30uCi n
buffer B supplemented with 32 mg/ml lactate dehydrogenase
(Roche), 60 mg/ml pyruvate kinase (Roche), 4 mM phosphoenolpyr-
uvate, and 0.4 mM NADH. For the ATPase activity of
reconstituted BmrC/BmrD (3 mg), buffer B was replaced by
50 mM Hepes pH 8 and measurements were done at 37uC.
Unless stated otherwise, ATP and MgCl2 were added at 4 mM
and 5 mM, respectively. Hoechst 33342 (Sigma) was dissolved at
1 mM in deionized water, and ortho-vanadate (Sigma) was
prepared at 100 mM as described previously [81] and heated at
95uC for 5 min before use. The initial rate of ATP hydrolysis was
plotted against the ATP concentration, and curve fitting was
performed using GraFit 5.0 (Erithacus Software). To avoid any
interference with the enzymes in the coupled enzymatic assay,
ATPase activity in the presence of fos-choline or LDAO was
measured by a colorimetric assay of Pi release, as previously
described [82].
2-D crystallisation and electron microscopy
50 ml of BmrC/BmrD at 0.5 mg/ml solubilized in 0.1%
DOTM was supplemented with a solubilized mixture of EPC/
EPA/cholesterol 7/1/2 (mol/mol) at lipid/protein ratio of 0.6–0.8
(w/w) in 50 mM Tris-HCl pH 8, 200 mM NaCl, 2.5 mM MgCl2
supplemented with 5 mM ATP and 2 mM ortho-vanadate. To
ensure a complete mixing of lipids and detergent, solubilized lipids
were prepared by mixing lipids and DOTM 1/4 (w/w) in
chloroform and after its evaporation, the dried film was
resuspended in water leading to a clear suspension. After overnight
incubation at 4uC of lipids, proteins and detergent, detergent was
slowly removed by 3 additions of 1 mg of Bio-Beads without
stirring, each addition being followed by a 24 hours incubation
period [83]. Vesicles appeared the second day while 2-D crystals
were observed the third day. 2-D crystals were stable for a week at
4uC.
For electron microscopy, 2-D crystals were negatively stained
with 2% uranyl acetate. Images were recorded under low dose
conditions on a SSC GATAN camera 102461024 pixel with a
CM120 Phillips electron microscope operating at 120 kV. Images
were recorded at a magnification of 45000 corresponding to a
resolution of 3.86 A ˚/pixel. Image analysis was performed with 2dx
package which included two cycle of lattice unbending (CCUN-
BENDK), calculation of defocus and astigmatism values
(CTFFIND) and correction of the contrast Fourier transform
(CTFAPPLY). Plane symmetry was established by analysis of the
images using ALL SPACE (Valpuesta et al., 1994) with IQ 1–5 up
to 20 A ˚. The five best images ranging in defocus from 20.4 to
20.8 mm were merged and used to calculate a projection map at
20 A ˚ resolution with p121-b symmetry (see Table S1 and Table
S2).
For cryo-electron microscopy of proteoliposomes, samples were
flash frozen in liquid ethane and images were recorded under low
dose conditions.
Supporting Information
Figure S1 Purification of BmrC/BmrD. Left panel, only
the BmrD subunit is histidine-tagged. Right panel, both BmrC and
BmrD are histidine-tagged. Lanes 1 and 5, membrane fractions;
lanes 2 and 6, supernatants obtained after membrane solubiliza-
tion with 1% FC12 (lanes 2) or 1% DDM (lanes 6) and
centrifugation (180,000 g, 1 h); lanes 3 and 7, unbound material
not retained on the Ni-Agarose chromatography column; lanes 4
and 8, material eluted from the Ni-Agarose chromatography
column in the presence of 250 mM imidazole. Positions of
molecular weights markers are indicated (in kDa) and those of
BmrC and BmrD are shown by grey or black arrowheads,
respectively. Please note that for the mono-tag construct (left
panel), more BmrC subunit is lost in the ‘unbound’ fraction (lanes
4 and 7) resulting in a non-stoichiometric recovery of BmrC/
BmrD.
(PDF)
Figure S2 ATPase activity of BmrC/BmrD purified
using different detergents. The ATPase activity was mea-
sured at 4 mM ATP and the value obtained with DDM
(140 nmol?min
21?mg
21) was taken as 100%.
(PDF)
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overexpressed alone and ATPase activities. (a) lanes 1,
membrane fractions; lanes 2, supernatants obtained after solubi-
lization with 1% DDM; lanes 3, unbound materials not retained
on the Ni-Agarose chromatography columns; lanes 4, proteins
eluted from the Ni-Agarose chromatography column in the
presence of 250 mM imidazole. Positions of molecular weight
markers are indicated (in kDa). (b) ATPase activities of BmrC and
BmrD purified separately (cf. lanes 4 in a) are compared to that
displayed by both proteins after their co-expression and joint
purification (either the wild-type transporter, BmrC/BmrD, or a
double mutant BmrC K377A/BmrD K469A). Measurements
were performed with 0.05% DDM as described in the Experi-
mental Procedures section, in the presence (+) or absence (2)o f
0.5 mM vanadate. Representative values are shown, expressed as
the mean 6 SD for three measurements for experiments
performed in the absence of vanadate.
(PDF)
Figure S4 ATPase activity of BmrC/BmrD proteolipo-
somes prepared in the presence of different detergents.
PC/PA(9:1 molar ratio) were solubilized with the indicated detergent
prior to incubation with purified BmrC/BmrD, and detergent was
removed using BioBeads. DM, decylmaltoside; TX-100, Triton X-
100; OTG, octylthioglucoside. The obtained proteoliposomes were
imaged using Cryo-TEM (b–d), and their ATPase activity was
assessed at 4 mM ATP (a). ATPase activities are expressed relative to
the value obtained for BmrC/BmrD reconstituted into DM
solubilized PC/PA (1.960.4 mmol?min
21?mg
21;n=5 ) .
(PDF)
Figure S5 Alignment of BmrC (YheI) and BmrD (YheH)
proteins. Protein sequences were obtained from the Subtilist
Web Server (http://genolist.pasteur.fr/SubtiList/). The alignment
was generated by ClustalW (1.8) on the NPS@ server (http://npsa-
pbil.ibcp.fr) using the default parameters except that PAM was used as
the weight matrix in the multiple alignment parameters window. The
figure was made with ESPript 2.0 (http://prodes.toulouse.inra.fr/
ESPript/). A blue frame was drawn when two residues were similar
(red letters in yellow boxes) or identical (white letters in red boxes). The
approximate boundary between the transmembrane domain (TMD)
and nucleotide-binding domain (NBD) is indicated. For the NBD, the
Walker A (WA) and B (WB) motifs and the ABC signature (ABC) are
underlined.Forthe TMD,the location oftheputative transmembrane
helices (numbered TMH1 to 6) is indicated above or below the
sequence for BmrC and BmrD, respectively, using the prediction
obtained from the following web servers: TopPred (http://mobyle.
pasteur.fr/cgi-bin/portal.py?form=toppred; cyan colored), TMH-
MM v. 2.0 (http://www.cbs.dtu.dk/services/TMHMM/; yellow-
green colored), PHDhtm (http://npsa-pbil.ibcp.fr/cgi-bin/npsa_au-
tomat.pl?page=/NPSA/npsa_htm.html; teal colored), HMMTOP
(http://www.enzim.hu/hmmtop/index.html; dark blue colored) and
DAS(http://www.sbc.su.se/,miklos/DAS/maindas.html;greencol-
ored). For TMHMM, PHDhtm, HMMTOP and DAS programs, the
default parameters were used. For TMHMM, this allowed the
prediction of 6 and 5 transmembrane helices for BmrC and BmrD,
respectively; the fifth putative transmembrane helix of BmrD was not
p r e d i c t e dt ob el o n ge n o u g ht og i v er i s et ot w od i f f e r e n t
transmembrane helices. With the PHDhtm program, only 5
transmembrane helices were predicted for both BmrC and BmrD
proteins, but the third one is very long in both cases and thus is
possibly split into two shorter transmembrane helices (the same
explanation holds true for the transmembrane predicition of BmrD
with the DAS program). With the latter program, only transmem-
brane helices whose maximal prediction values were above the strict
cutoff (.2.2) were considered.ForBmrC, the DAS program identified
an additional putative transmembrane helice that was, however, only
8 residues long (133–140), and thus is not shown in the figure (this
stretch likely represents the beginning of TMH3 of BmrC which is
otherwise predicted to start at residue 143). With the TopPred
program, the default parameters used initially predicted only 5 and 4
transmembrane helices for BmrC and BmrD, respectively. However,
the use of less stringent parameters, as indicated below, with the
hydrophobicity GES-scale allowed the prediction of 6 transmembrane
helices for both proteins as shown in the figure; full window size: 18
(BmrC) and 14 (BmrD); core window size: 8 (BmrC) and 6 (BmrD);
wedge window size: 5 (BmrC) and 4 (BmrD); cutoff for certain and
putative transmembrane segments: 1.4 and 1.1, respectively; critical
distance between 2 transmembrane segments: 1 and Critical loop
length: 1.
(PDF)
Table S1 Phase Residuals in Resolution Ranges. Phase
residuals in degrees, obtained during merging of five negatively
stained 2D crystal image data. Columns show resolution range in A ˚.
IQ=1….8, intensity quotient categories of reflections (1); All IQs,
average phase residuals with equal reflection weighting; IQ-wght,
average phase residual with IQ-weighting. In each resolution range
(Dmin to Dmax in A ˚), the phase residuals (upper row) and the
number of reflections (lower row) are given. This table gives suitable
phase residuals up to 20 A ˚ resolution and the projection map data
were limited to this resolution. Reference: (1) Henderson, R.,
Baldwin, J.M., Ceska, T.A., Zemlin, F., Beckmann, E. and
Downing, K.H. (1990). J. Mol. Biol. 213, 899–929.
(PDF)
Table S2 Internal phase residuals of all possible two-
sided plane groups using a representative image. Internal
phase residuals were determined using the program ALLSPACE
(Valpuesta et al., 1994) from spots of IQ1 to IQ5 to 20 A ˚
resolution.
a Phase residual versus other spots (90u random).
b Target residual based on statistics taking Friedel weight into
account.
c Note that in space group p1 no phase comparison is
possible, so the numbers given here are theoretical phase residuals
based on the signal-to-noise ratio of the observed diffraction spots.
* acceptable, ! should be considered, ‘possibility.
(PDF)
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